Cardiac Ablation Clinical Trials

Clinical trials related to Cardiac Ablation Procedure

Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The objective of the study is to collect data on the usability and integration of the VERAFEYE Imaging and Guidance System in adult patients indicated to undergo a standard of care catheter-based ablation procedure for the treatment of Atrial Flutter (AFL), paroxysmal AF (PAF) or persistent AF (perAF). Results from this study may be used to guide development and refinement the VERAFEYE Imaging and Guidance System capabilities.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• IC1: Subject is at least 18 years of age at the time of consent

• IC2: Subject is scheduled to undergo a standard of care catheter-ablation procedure to treat AFL/AF, according to current international and local guidelines and per physician discretion

• IC3: Subject is able to understand and willing to provide written informed consent

• IC4: Subject is able and willing to complete all study assessments associated with this clinical study at an approved clinical study site

Locations
Other Locations
Croatia
Klinicki Bolnicki Centar (KBC) Split
RECRUITING
Split
Contact Information
Primary
Ivan Sikiric
ivan.sikiric20@gmail.com
+385958934912
Backup
Ivan Aranza
aranza.ivan@gmail.com
+385917947452
Time Frame
Start Date: 2026-03-03
Estimated Completion Date: 2026-08-15
Participants
Target number of participants: 50
Treatments
Experimental: Atrial Fibrillation and Atrial Flutter arm
Subjects entitled to undergo a catheter-based ablation treatment for typical atrial flutter and/or atrial fibrillation
Related Therapeutic Areas
Sponsors
Leads: LUMA Vision Ltd.

This content was sourced from clinicaltrials.gov